Overview

Ciclosporin to Protect Renal Function In Cardiac Surgery

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the potential of ciclosporin in reducing risk and degree of acute kidney injury after cardiac surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Region Skane
Collaborator:
NeuroVive Pharmaceutical AB
Treatments:
Cyclosporine
Cyclosporins